» Authors » Hyejeong Jang

Hyejeong Jang

Explore the profile of Hyejeong Jang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 252
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Scofield S, Koshko L, Stilgenbauer L, Booms A, Berube R, Kassotis C, et al.
Sci Total Environ . 2025 Mar; 971:179060. PMID: 40068415
Type 2 Diabetes Mellitus (T2DM) is a significant public health burden. Emerging evidence links volatile organic compounds (VOCs), such as benzene to endocrine disruption and metabolic dysfunction. However, the effects...
2.
Scofield S, Koshko L, Stilgenbauer L, Booms A, Berube R, Kassotis C, et al.
bioRxiv . 2025 Jan; PMID: 39763906
Background: Type 2 Diabetes Mellitus (T2DM) is a significant public health burden. Emerging evidence links volatile organic compounds (VOCs), such as benzene to endocrine disruption and metabolic dysfunction. However, the...
3.
Hadid T, Biedny A, Mamdani H, Azmi A, Kim S, Jang H, et al.
Ther Adv Vaccines Immunother . 2024 Dec; 12:25151355241309095. PMID: 39737331
Background: Cannabis (CAN) use has risen significantly over the last few decades. CAN has potent immunosuppressive properties, which could antagonize the effect of immunotherapy (IO). The impact of CAN use...
4.
Bae T, Sung K, Pham T, Najy A, Zamiri A, Jang H, et al.
Cancer Res . 2024 Nov; 85(2):342-359. PMID: 39531508
Genetic alterations play a pivotal role in various human diseases, particularly cancer. The androgen receptor (AR) is a crucial transcription factor driving prostate cancer progression across all stages. Current AR-targeting...
5.
Bannoura S, Aboukameel A, Khan H, Uddin M, Jang H, Beal E, et al.
Cancer Lett . 2024 Sep; 604:217275. PMID: 39321913
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy, with limited therapeutic options. Here, we evaluated the role of regulator of chromosome condensation 1 (RCC1) in PDAC. RCC1 functions as...
6.
Jain D, Zaeim F, Wahidi M, Smith W, Alkaram W, Abu-Jamea A, et al.
Gynecol Oncol . 2024 Sep; 190:272-282. PMID: 39265465
Objective: To assess the influence of geographies and race on the survival outcomes in patients diagnosed with cervical squamous cell carcinoma (CSCC) across three continents. Methods: This multicontinental retrospective study...
7.
Assad H, Levitin M, Petrucelli N, Manning M, Thompson H, Chen W, et al.
Breast Cancer Res Treat . 2024 Apr; 206(2):261-272. PMID: 38605155
Purpose: Carriers of pathogenic variants in BRCA1/2 have an elevated lifetime cancer risk warranting high-risk screening and risk-reducing procedures for early detection and prevention. We report on prevention practices among...
8.
Abada E, Kim S, Jang H, Kheil M, Singh K, Bandyopadhyay S, et al.
Gynecol Oncol . 2024 Feb; 185:25-32. PMID: 38364692
Objectives: To study the expression of HER2 in high-grade FIGO3 endometrial endometroid carcinoma (EEC) and to correlate our findings with the clinicopathologic characteristics of this tumor. Methods: HER2 expression by...
9.
Bannoura S, Aboukameel A, Khan H, Uddin M, Jang H, Beal E, et al.
bioRxiv . 2024 Jan; PMID: 38187605
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with limited therapeutic options. Here we for the first time evaluated the role of regulator of chromosome condensation 1 (RCC1) in...
10.
Azar I, Austin A, Saha B, Kim S, Jang H, Al Sbihi A, et al.
Clin Lung Cancer . 2023 May; 24(5):e179-e186. PMID: 37217388
Background: Historically, limited stage Small Cell Lung Cancer (SCLC) has been treated with concurrent chemoradiation (CRT). While current NCCN guidelines recommend consideration of lobectomy in node-negative cT1-T2 SCLC, data regarding...